GlassScriptPhysician profile
Joseph Melancon
NPI 1760432108
$236,940.87
in general payments reported to CMS, 2019-2025
28 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $52K · 2021: $8,032 · 2022: $97K · 2023: $7,479 · 2024: $1,024 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,000 · Food and Beverage: $3,204 · Travel and Lodging: $2,073 · Consulting Fee: $500 · Education: $65.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,000.00 |
| Food and Beverage | $3,203.62 |
| Travel and Lodging | $2,073.24 |
| Consulting Fee | $500.00 |
| Education | $65.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $219,594.16 | 2019-2025 | Envarsus |
| Potrero Medical, INC. | $9,538.33 | 2021-2022 | |
| Asensus Surgical, INC. | $3,891.46 | 2019 | |
| Abbvie INC. | $421.55 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $361.83 | 2023-2025 | Ultomiris, Soliris |
| Boston Scientific Corporation | $329.49 | 2023-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Dilon Technologies, INC. | $327.31 | 2025 | Hemoblast Bellows |
| Shionogi INC | $307.01 | 2024-2025 | Fetroja |
| Medtronic, INC. | $265.22 | 2024-2025 | Sonicision, Signia |
| Sanofi-Aventis U.S. LLC | $253.31 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $231.66 | 2020-2025 | Terlivaz, Acthar |
| Gilead Sciences, INC. | $191.59 | 2023-2025 | Livdelzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.39 | 2024-2025 | Xifaxan |
| Acera Surgical, INC. | $160.86 | 2025 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $155.42 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $133.37 | 2024 | Rezdiffra |
| Mallinckrodt Enterprises LLC | $104.96 | 2019 | |
| Abbott Laboratories | $102.83 | 2019 | |
| Merck Sharp & Dohme LLC | $72.67 | 2025 | Prevymis |
| Covidien LP | $56.93 | 2019 | |
| Davol INC. | $55.05 | 2021 | |
| Intercept Pharmaceuticals, INC. | $44.95 | 2024-2025 | |
| Melinta Therapeutics, LLC | $31.55 | 2024 | Rezzayo, Vabomere |
| Ethicon US, LLC | $28.22 | 2025 | Evarrest, Prolene, Surgicel Nu-Knit |
| Baxter Healthcare | $28.20 | 2023 | Floseal |
| Takeda Pharmaceuticals U.S.A., INC. | $26.06 | 2022 | |
| Teleflex LLC | $23.10 | 2023 | Quikclot |
| Stryker Corporation | $19.39 | 2023 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Melancon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.